Clinical TrialsSearch results
Number of results: 204
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Randomized pilot study comparing safety of irinotecan+S-1(IRIS)+bevacizumab and mFOLFIRI+bevacizumab for metastatic colorectal cancer (T-CORE0702)
- 1st line or 2nd line therapy for unresectable colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2007-07-22
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Recruiting
- Study of Ninjinyoeito for frail in dialysis patients
- kidney failure
- OTA HIDETAKA
- 2020-09-01
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Multicenter study for combined therapy of prednisolone and cyclosporin in refractory nephrotic syndrome
- membranouos nephropathy and focal segmental glomerulosclerosis with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome
- membranous nephropathy with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- A phase II study of the Cladribine and Rituximab combination therapy for relapsed and refractory indolent B-cell Non-Hodgkin's Lymphoma.
- low grade B cell lymphoma
- refractory lymphoma treatment study group
- 2008-12-18